EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review of KSHV: Lifecycle, Tumorigenesis, Immune Evasion and Therapeutic Strategies

Chaoran Zhuo, Dongdong Cao, Fangling Li

Viruses · 2026

DOI: 10.3390/v18101053 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Chaoran Zhuo und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shihezi University, Shihezi 832002, China. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Immune Evasion, Carcinogenesis, Herpesviridae Infections. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xinjiang Production and Construction Corps, Shihezi University, National College Students Innovative Entrepreneurial Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi’s sarcoma-associated herpesvirus (KSHV) is an important human gamma-herpesvirus, particularly with a significant incidence rate among AIDS patients and other immunosuppressed populations. This review introduces the basic virological characteristics of KSHV and elucidates the core molecular mechanisms underlying KSHV tumorigenesis. Clinical management primarily focuses on KSHV-related diseases, utilizing antiretroviral therapy, chemotherapy, radiotherapy, and therapies targeting specific targets. However, there still lack of specific anti-KSHV drugs in terms of treatment. Current research is increasingly directed toward novel therapeutic strategies, including those that sustain viral latency or promote lytic reactivation, alongside antigen-based immunotherapeutic approaches. Despite significant breakthroughs in research, the precise regulatory network of KSHV latent infection, the complex interactions between the virus and the host microenvironment (especially inflammatory and immune cells), as well as the development of highly effective and low-toxicity specific antiviral drugs, remain major challenges for the future. A deep understanding of the pathogenic mechanisms of KSHV will lay a solid foundation for the development of more effective prevention, diagnosis, and treatment methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanImmune EvasionCarcinogenesisHerpesviridae InfectionsHumansVirus LatencySarcoma, KaposiAnimalsAntiviral AgentsVirus Activation

Stichwörter der Autor:innen

Kaposi’s sarcoma-associated herpesvirusRTAimmune evasiontherapeutic strategies

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • School of Medicine, Shihezi University, Shihezi 832002, China.

Förderung

  • Xinjiang Production and Construction Corps
  • Shihezi University
  • National College Students Innovative Entrepreneurial Project

Zitieren

APA

Zhuo, C., Cao, D., & Li, F. (2026). A Review of KSHV: Lifecycle, Tumorigenesis, Immune Evasion and Therapeutic Strategies. Viruses. https://doi.org/10.3390/v18101053

Vancouver

Zhuo C, Cao D, Li F. A Review of KSHV: Lifecycle, Tumorigenesis, Immune Evasion and Therapeutic Strategies. Viruses. 2026. doi:10.3390/v18101053

BibTeX
@article{Zhuo2026,
  author = {Zhuo, Chaoran and Cao, Dongdong and Li, Fangling},
  title = {A Review of KSHV: Lifecycle, Tumorigenesis, Immune Evasion and Therapeutic Strategies},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18101053}
}
Kostenlos starten →